ArticleFrontiers in pharmacology2021

Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score.

Yongjiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.